Genetic abnormalities as biological tumor markers
Rosen, N.; Israel, M.A.
Seminars in Oncology 14(2): 213-231
1987
ISSN/ISBN: 0093-7754 PMID: 2884729 Document Number: 298546
Document emailed within 1 workday
Related Documents
Ivanov, V.I.; Levina, L.I.; Konstantinova, L.M.; Zaiarnyĭ, A.N.; Antonenko, V.G. 1992: Computerized analysis in the study of multiple congenital defects connected with chromosome abnormalities: phenotype-karyotypic relations and genetic markers Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 4: 24-30Ruddon, R.W.; Norton, S.E. 1993: Use of biological markers in the diagnosis of cancers of unknown primary tumor Seminars in Oncology 20(3): 251-260
Castelli, M.; Sega, F.M.; Sciarretta, F.; Casale, V.; Coloni, F.; Sega, E. 1983: The biological and clinical significance of tumor markers in tissue extracts Cancer Detection and Prevention 6(1-2): 61-66
Yamamoto, H.; Itoh, F.; Imai, K. 1996: Detection of tumor markers by genetic diagnostic methods and its clinical application Nihon Rinsho. Japanese Journal of Clinical Medicine 54(6): 1574-1579
Shackney, S.E.; Pollice, A.A.; Smith, C.A.; Alston, L.; Singh, S.G.; Janocko, L.E.; Brown, K.A.; Petruolo, S.; Groft, D.W.; Yakulis, R.; Hartsock, R.J. 1996: The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications Cancer Journal from Scientific American 2(2): 106-113
Nozawa, S.; Udagawa, Y.; Sasaki, H.; Ito, K.; Akiya, K.; Terashima, Y.; Takamizawa, H.; Ohkura, H.; Fujimoto, S.; Hashimoto, M. 1992: Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2085-2093
Hou, J.-X.; Yang, X.-Q.; Chen, C.; Jiang, Q.; Yang, G.-L.; Li, Y. 2011: Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis Hepato-Gastroenterology 58(106): 632-636
Cacabelos, R. 1993: Genetic markers in neuropsychiatric disorders: genetic cartography and diagnostic and therapeutic explorations (II) Medicina Clinica 100(1): 28-36
Kravchuk, O.I.; Spitsyn, V.A.; Ginter, E.K.; Makarov, S.V. 1996: Population genetic characteristics of highland and meadow Mari. Genetic markers Genetika 32(4): 570-575
Altukhov, I.P.; Kurbatova, O.L.; Botvin'ev, O.K.; Afanas'ev, K.I.; Malinina, T.V. 1981: Genetic markers and diseases: the genetic, anthropometric and clinical characteristics of children with acute pneumonia Genetika 17(5): 920-931
Rudneva, I.A.; Germanov, A.B.; Miasnikova, I.A.; Sokolov, M.I. 1970: Genetic markers of herpes simplex virus. 2. Study of genetic markers of the US strain of herpes simplex virus of the 3d antigenic group Voprosy Virusologii 15(2): 182-186
Khalifa, A.; Mady, E.A.; Abadeer, N.; Kamal, A. 1999: Differential tumor markers and hepatitis markers profile in liver tumors Anticancer Research 19(4a): 2495-2500
Muramatsu, T. 1988: Function of carbohydrate chains serving as tumor-markers and differentiation markers Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 79: 27-36
Nano, M.; Ricci, E.; Pecchio, F.; Rapellino, M.; Giaccone, M.; Molaschi, M. 1988: Relations between markers and immunological status in surgical patients. Tumor markers and immunity in surgery Minerva Medica 79(11): 943-946
Snel, B.J.; Ypma, T.D. 2008: Examples of preimplantation genetic diagnosis versus prenatal diagnosis in carriers of genetic abnormalities: advantages and disadvantages Nederlands Tijdschrift Voor Geneeskunde 152(13): 768-771
Rivera Muñoz, J.E.; Leis Márquez, M.T.; García-Cavazos, R.J.; Hernández Andrade, E.A.; Guzmán Huerta, M.E.; Rodríguez-Bosch, M.R. 1997: Usefulness of ultrasonographic markers in chromosomal abnormalities Ginecologia y Obstetricia de Mexico 65: 394-399
Wang, J.; Coltrera, M.D.; Gown, A.M. 1995: Abnormalities of p53 and p110RB tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 8(8): 837-842
Osmak, M.; Niksíc, D.; Brozović, A.; Ristov, A.A.; Vrhovec, I.; Skrk, J. 1999: Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis Anticancer Research 19(4b): 3193-3197
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Loperfido, F.; Digaetano, A.; Ansalone, G.; Bellocci, F.; Mongiardo, R.; Marino, B.; Santarelli, P. 1981: Hypertrophic cardiomyopathy: ECG-VCG abnormalities in absence of the echocardiographic markers in a family Giornale Italiano di Cardiologia 11(9): 1266-1275